AL Amyloidosis for the Cardiologist and Oncologist
AL amyloidosis results from clonal production of immunoglobulin light chains, most commonly arising from a clonal plasma cell disorder. Once considered a nearly uniformly fatal disease, prognosis has improved markedly over the past 15 years, predominantly because of advances in light chain suppressi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-09-01
|
| Series: | JACC. CardioOncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666087319300134 |